Navari R - Search Results

1

2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents.

Herrstedt J, Celio L, Hesketh PJ, Zhang L, Navari R, Chan A, Saito M, Chow R, Aapro M. Herrstedt J, et al. Among authors: navari r. Support Care Cancer. 2023 Dec 21;32(1):47. doi: 10.1007/s00520-023-08221-4. Support Care Cancer. 2023. PMID: 38127246 Free PMC article.

2

2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy.

Herrstedt J, Roila F, Warr D, Celio L, Navari RM, Hesketh PJ, Chan A, Aapro MS. Herrstedt J, et al. Support Care Cancer. 2017 Jan;25(1):277-288. doi: 10.1007/s00520-016-3313-0. Epub 2016 Jul 22. Support Care Cancer. 2017. PMID: 27443154 Review.

3

2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting.

Einhorn LH, Rapoport B, Navari RM, Herrstedt J, Brames MJ. Einhorn LH, et al. Support Care Cancer. 2017 Jan;25(1):303-308. doi: 10.1007/s00520-016-3449-y. Epub 2016 Nov 4. Support Care Cancer. 2017. PMID: 27815710

4

Should palonosetron be a preferred 5-HT₃ receptor antagonist for chemotherapy-induced nausea and vomiting? An updated systematic review and meta-analysis.

Chow R, Warr DG, Navari RM, Tsao M, Popovic M, Chiu L, Milakovic M, Lam H, DeAngelis C. Chow R, et al. Among authors: navari rm. Support Care Cancer. 2018 Aug;26(8):2519-2549. doi: 10.1007/s00520-018-4237-7. Epub 2018 May 23. Support Care Cancer. 2018. PMID: 29796708

5

Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) in highly emetogenic chemotherapy (HEC) patients.

Chow R, Chiu L, Herrstedt J, Aapro M, Lock M, DeAngelis C, Navari RM. Chow R, et al. Among authors: navari rm. Support Care Cancer. 2021 Aug;29(8):4269-4275. doi: 10.1007/s00520-020-05977-x. Epub 2021 Jan 7. Support Care Cancer. 2021. PMID: 33409724

6

Olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting: a systematic review, meta-analysis, cumulative meta-analysis and fragility assessment of the literature.

Chow R, Herrstedt J, Aapro M, Chiu L, Lam H, Prsic E, Lock M, DeAngelis C, Navari RM. Chow R, et al. Among authors: navari rm. Support Care Cancer. 2021 Jul;29(7):3439-3459. doi: 10.1007/s00520-020-05935-7. Epub 2021 Jan 13. Support Care Cancer. 2021. PMID: 33442782 Free PMC article.

7

Olanzapine 5 mg vs 10 mg for the prophylaxis of chemotherapy-induced nausea and vomiting: a network meta-analysis.

Chow R, Navari RM, Terry B, DeAngelis C, Prsic EH. Chow R, et al. Among authors: navari rm. Support Care Cancer. 2022 Feb;30(2):1015-1018. doi: 10.1007/s00520-021-06606-x. Support Care Cancer. 2022. PMID: 34613472 No abstract available.

8

Single-dose NEPA versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy.

Zelek L, Navari R, Aapro M, Scotté F. Zelek L, et al. Among authors: navari r. Cancer Med. 2023 Aug;12(15):15769-15776. doi: 10.1002/cam4.6121. Epub 2023 Aug 3. Cancer Med. 2023. PMID: 37537943 Free PMC article. Clinical Trial.

9

Efficacy and safety of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) as reported in phase I and II studies: a systematic review.

Chow R, Chiu L, Navari R, Passik S, Chiu N, Popovic M, Lam H, Pasetka M, Chow E, DeAngelis C. Chow R, et al. Among authors: navari r. Support Care Cancer. 2016 Feb;24(2):1001-1008. doi: 10.1007/s00520-015-3000-6. Epub 2015 Nov 4. Support Care Cancer. 2016. PMID: 26530228 Review.

10

Efficacy of olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis.

Chiu L, Chow R, Popovic M, Navari RM, Shumway NM, Chiu N, Lam H, Milakovic M, Pasetka M, Vuong S, Chow E, DeAngelis C. Chiu L, et al. Among authors: navari rm. Support Care Cancer. 2016 May;24(5):2381-2392. doi: 10.1007/s00520-016-3075-8. Epub 2016 Jan 15. Support Care Cancer. 2016. PMID: 26768437 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters